title: Liposome encapsulated daunorubicin doubles anthracycline toxicity in cell lines showing a non-PGP related multidrug resistance.
authors.forename: M
authors.initials: M
authors.lastname: Michieli
authors.forename: D
authors.initials: D
authors.lastname: Damiani
authors.forename: A
authors.initials: A
authors.lastname: Ermacora
authors.forename: P
authors.initials: P
authors.lastname: Masolini
authors.forename: A
authors.initials: A
authors.lastname: Michelutti
authors.forename: M
authors.initials: M
authors.lastname: Baccarani
mesh_terms: D018943:Anthracyclines / Q000008:administration & dosage / Q000633:toxicity; D003630:Daunorubicin / Q000008:administration & dosage* / Q000378:metabolism / Q000633:toxicity*; D004339:Drug Compounding / Q000379:methods*; D018432:Drug Resistance, Multiple; D006801:Humans; D008081:Liposomes / Q000008:administration & dosage* / Q000378:metabolism; D014407:Tumor Cells, Cultured / Q000187:drug effects
chemical_list: D018943:Anthracyclines; D008081:Liposomes; D003630:Daunorubicin